Detection of SARS-CoV-2 E gene RNA / RdRp/S gene RNA / N gene RNA using real-time RT-PCR.

Specimen Type: Nasopharyngeal Swab & Oropharyngeal Swab in VTM
.LTAT (Hours) : 24 – 36

Detection of SARS-CoV-2 antigen using rapid test kit

Specimen Type: Nasopharyngeal Swab
LTAT (Hours) : 12 – 24

Detection of SARS-CoV-2 IgM and IgG antibodies using rapid chromatographic test kit

.

Specimen Type: 1 x 3 mL Plain Blood
LTAT (Hours) :12 – 24

The COVID-19 Quantitative Neutralizing Antibody Test is an immunoassay for the in vitro quantitative determination of total antibodies (including IgG) to the SARS-CoV-2 spike (S) protein receptor binding domain (RBD) in human serum and plasma. The test is intended as an aid to assess the adaptive humoral immune
response to the SARS-CoV-2 S protein. The test results correlate 92.3% with serum neutralization test for neutralizing antibodies against SARS-CoV-2 and the concentration is reported in WHO standard unit, which is the Binding Antibody Unit (BAU/mL).

Specimen Type: 1 x 5 mL Plain Blood
LTAT (Hours) : 24 – 48

Influenza A typing (H1N1, H5N1, H3N2 and H7N9) using real-time RT-PCR

 

Specimen Type: Nasal / Nasopharyngeal Swab in VTM
LTAT (Hours) : 24

Detection of Influenza A, Influenza B and Respiratory Syncytial Virus, including typing of Influenza A (H1N1, H5N1, H3N2 and H7N9) using real-time RT-PCR.

 

Specimen Type: Nasal / Nasopharyngeal Swab in VTM
LTAT (Hours) : 24

Detection of 26 respiratory viruses and bacteria using real-time RT-PCR:

  • Influenza A, B & RSV
  • H1N1, H3N2, H5N1, H7N9
  • Parainfluenza 1, 2, 3, 4
  • Coronavirus NL63, 229E, OC43, HKU1
  • Adenovirus, Metapneumovirus & Enterovirus
  • Rhinovirus & Bocavirus
  • Mycoplasma pneumoniae, Chlamydophila pneumoniae, Streptococcus pneumoniae & Legionella pneumophila
  • Haemophilus influenzae
  • Moraxella catarrhalis

Specimen Type: Nasal / Nasopharyngeal Swab in VTM
LTAT (Hours) : 24

Nucleic acid testing for the detection of Hepatitis B Virus DNA, Hepatitis C Virus RNA and Human Immunodeficiency Virus RNA

 

Specimen Type: 1 x 8 mL EDTA Plasma/Serum
LTAT (Hours) : 24 – 48

Nucleic acid testing for the detection of Hepatitis B Virus DNA

 

Specimen Type: 1 x 8 mL EDTA Plasma/Serum
LTAT: 7 Day

Nucleic acid testing for the detection of Hepatitis C Virus RNA

 

Specimen Type: 1 x 8 mL EDTA Plasma/Serum
LTAT: 7 Days

Nucleic acid testing for the detection of Human Immunodeficiency Virus RNA

 

Specimen Type: 1 x 8 mL EDTA Plasma/Serum
LTAT (Hours) : 24 – 48

Viral load testing of Hepatitis B viral DNA using quantitative fluorescence real-time RT-PCR

 

Specimen Type: 1 x 5 mL EDTA Plasma/Serum
LTAT: 3 Days

Viral load testing of Hepatitis C viral RNA using quantitative fluorescence real-time RT-PCR

 

Specimen Type: 1 x 5 mL EDTA Plasma/Serum
LTA: 3 Days

Hepatitis C viral genotyping of 1a, 1b, 2, 3, 4, 5 and 6 using fluorescence real-time RT-PCR

 

Specimen Type: 2 x 5 mL EDTA Plasma/Serum
LTAT: 3 Days

Viral load testing and genotyping of 1a, 1b, 2, 3, 4, 5 and 6 of Hepatitis C viral RNA using quantitative fluorescence real-time RT-PCR

 

Specimen Type: 1 x 5 mL EDTA Plasma/Serum
LTAT: 3 Days

Get intouch with us to find out more about the solutions we provide at Synapse

Our Vision

To become the leading regional healthcare testing provider by offering unique screening and diagnostic solutions that better the nature of conventional healthcare services.